24-013488 nhlbi requires response to a european office action in order to advance protection of claims covering isotopes of alpha-ketoglutarate used in the hyperpolarized MR imaging of multiple cancer…
Ended Awarded Last action
- Contract number
- 75N92024F00029
- Awardee
-
Cantor Colburn LLP UEI LE9VLFQANN43
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,385
Award facts
- Opportunity
-
- 20CCLCHM006224 Solicitation number
- Contract value 100% obligated
- $13,385.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541110 Offices of Lawyers
- PSC
- R418 Support- Professional: Legal
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Hartford, CT 06103, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, with an ID of 75N98020D00060|75N92024F00029, was issued by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract was awarded to the law firm Cantor Colburn LLP, a prime contractor on the NIH Patent Legal Services indefinite-delivery/indefinite-quantity (IDIQ) contract, a $115 million master IDIQ that enables NIH institutes and centers, as well as the Centers for Disease Control and Prevention, to obtain patent prosecution, counseling, and litigation support services. Under this task order, Cantor Colburn LLP will provide a response to a European Office Action in order to advance the protection of claims covering isotopes of alpha-ketoglutarate used in the hyperpolarized MR imaging of multiple cancer types. The contract is a firm-fixed-price delivery order with a ceiling value of $13,385 and an ultimate completion date of October 2, 2024. The contract does not have a set-aside designation.
Description
24-013488 nhlbi requires response to a european office action in order to advance protection of claims covering isotopes of alpha-ketoglutarate used in the hyperpolarized MR imaging of multiple cancer types.
Quick answers
Who was awarded contract 75N92024F00029?
75N92024F00029 was awarded to Cantor Colburn LLP by National Heart Lung and Blood Institute (National Institutes of Health) on July 3, 2024.
How much is contract 75N92024F00029 worth?
The government has obligated $13,385 on 75N92024F00029.
Is contract 75N92024F00029 an order under another contract?
Yes. 75N92024F00029 is a delivery order under 75N98020D00060, an indefinite delivery contract, on NIH Patent Legal Services.
Was contract 75N92024F00029 competed?
The extent of competition for 75N92024F00029 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award